By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



204 Cherwell Drive

Cary  North Carolina  27513  U.S.A.
Phone: 919-678-9512 Fax:



Company News
North Carolina's NephroGenex (NRX) Files for Chapter 11 and Seeks Sale 5/2/2016 10:02:48 AM
NephroGenex (NRX), Under Threat of Being Delisted from the NASDAQ, Fires CEO and CSO 4/14/2016 6:31:46 AM
NephroGenex (NRX) Halts Clinical Program of Lead Drug, Will Take Time to Restructure and Go Over Strategic Alternatives 2/24/2016 7:29:01 AM
NephroGenex (NRX) To Host Conference Call And Webcast On Fourth Quarter And Full Year 2015 Financial Results On Thursday, February 25, 2016 2/16/2016 12:07:01 PM
NephroGenex (NRX) To Present At The 18th Annual BIO CEO & Investor Conference 1/27/2016 9:46:50 AM
NephroGenex (NRX) Announces Independent DSMB Recommendation To Continue Phase 3 Study Of Oral Pyridorin In Diabetic Nephropathy Without Modification 1/22/2016 10:17:00 AM
NephroGenex (NRX) To Participate In Two Healthcare Conferences In January 1/6/2016 12:12:57 PM
NephroGenex (NRX) Announces Formation Of Scientific Advisory Board 1/5/2016 11:27:56 AM
NephroGenex (NRX) Announces FDA Clearance Of IND Application For Clinical Study Of Intravenous Pyridorin In The Treatment Of Acute Kidney Injury 12/14/2015 7:54:31 AM
NephroGenex (NRX) Reports Third Quarter 2015 Financial Results 11/12/2015 12:21:09 PM